XT
TARA icon

XTX Topco’s Protara Therapeutics TARA Stock Holding History

XTX Topco’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$306K Sell
58,801
-56,562
-49% -$335K 0.01% 2466
2025
Q4 		$615K Buy
+115,363
New +$641K 0.02% 1418
2025
Q1 		– Sell
-11,740
Closed -$62K – 3089
2024
Q4 		$62K Sell
11,740
-20,942
-64% -$67.7K 0.01% 1861
2024
Q3 		$59.8K Buy
+32,682
New +$67.1K ﹤0.01% 1669

Other funds holding TARA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

XTX Topco's TARA Position: Q1 2026 in Review

XTX Topco reduced its Protara Therapeutics (TARA) stake by 49% in Q1 2026, selling an estimated $335K and leaving 58,801 shares worth $306K. The position accounts for 0.01% of the portfolio, ranked #2466.

XTX Topco first reported a position in TARA in Q3 2024 and has held it in 4 quarters since. The position peaked at $615K in Q4 2025. 114 funds tracked by Wall St. Rank hold TARA as of Q1 2026.

  • XTX Topco held 58,801 shares of Protara Therapeutics worth $306K as of Q1 2026.
  • XTX Topco sold 56,562 Protara Therapeutics shares in Q1 2026, an estimated $335K.
  • Protara Therapeutics made up 0.01% of XTX Topco's portfolio in Q1 2026, its #2466 holding.
  • XTX Topco first reported a position in Protara Therapeutics in Q3 2024 and has held it in 4 quarters since.
  • XTX Topco's Protara Therapeutics position peaked at $615K in Q4 2025.
  • 114 funds tracked by Wall St. Rank held Protara Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.